Neuromod

Neuromod is a global medical technology company with offices in Ireland, Germany and the United States of America. Neuromod is the standard bearer for scientifically proven tinnitus treatment. 

Through the development of innovative technology, investment in clinical research, and collaboration with leading hearing and tinnitus care professionals, Neuromod is redefining tinnitus care.

Lenire Tinnitus Treatment Device

Lenire is a non-invasive, at-home bimodal neuromodulation tinnitus treatment device that has been proven in large-scale clinical trials and with real world patients.

Lenire® combines mild pulses to the tongue, through an intraoral Tonguetip®, with auditory stimulation through headphones to drive relief from tinnitus. This combination of stimuli is known as bimodal neuromodulation. 

In 2023, Lenire became the first device of its kind approved for the treatment of tinnitus in the USA following a De Novo grant from the US FDA. Lenire also has CE-mark certification and is available under the supervision of a qualified healthcare professional throughout Europe and the USA.

How Does Lenire Work?

Lenire’s bimodal neuromodulation stimulates the auditory and somatosensory nerves at once. This dual stimulation leverages the brain’s neuroplasticity to reduce focus on tinnitus. 

Lenire’s proprietary audio plays through bluetooth headphones to stimulate the auditory nerve and this is combined with mild pulses to the surface of the tongue using a small intra-oral Tonguetip®.

Lenire is used for two 30-minute sessions per day for a period of time recommended by a hearing healthcare professional. Patients are guided through the process by a tinnitus expert. 

Patients attend regular follow-up appointments to benchmark their tinnitus as they use Lenire.This has been proven to provide significant relief from tinnitus.^1,2,3,4

Lenire: Evidence Based Tinnitus Treatment Technology 

Lenire has the largest volume of evidence for a tinnitus treatment device in existence. Lenire has been subject to three large-scale clinical trials and has had real world evidence peer-reviewed and published in prestigious scientific journals. 

Both clinical trial and real world evidence supports Lenire as an effective tinnitus treatment. Here are some key takeaways from Lenire’s research:

• TENT-A1 Clinical Trial: 86% of patients reported a reduction in tinnitus severity, 80.1% of whom reported relief that sustained for at least 12 months post-treatment.  This was the cover story in Science Translational Medicine.
• TENT-A2 Clinical Trial: 95% of TENT-A3 participants reported tinnitus improvement, 91% of whom had relief that sustained for at least 12-months. Nature – Scientific Reports peer-reviewed and published TENT-A2.
• TENT-A3 Controlled Clinical Trial: 70% of patients with moderate or worse tinnitus had clinically meaningful relief from tinnitus with Lenire. This is compared with negligible improvement from sound-therapy, the trial’s control. TENT-A3 was pivotal in Lenire being awarded a De Novo Approval Grant from the US FDA. Nature Communications peer-reviewed and published TENT-A3. 
• Peer Reviewed Real World Data: 91.5% of 220 real world patients treated with Lenire reported significant relief from tinnitus. Nature Communications Medicine peer-reviewed and published this real world evidence.

Visit lenire.com/clinical-trials to learn more about Neuromod’s commitment to advancing the science of neuromodulation for tinnitus treatment.

Neuromod Scientific Advisory Board

Neuromod Devices assembled a Science Advisory Board of opinion leading scientists in the field of tinnitus research to provide guidance on the company’s research. This Scientific Advisory Board includes Professor Berthold Langguth, Prof. Sven Vanneste, and Prof. Deborah Hall.

Where Can Tinnitus Patients Access Lenire?

Lenire is available exclusively through the following qualified tinnitus care providers in Europe and the United States of America. Patients must attend a tinnitus assessment to see if Lenire is the right fit for their tinnitus. 

You can find an expert tinnitus clinic near you by visiting lenire.com/find-a-clinic.

How Can Hearing Healthcare Professionals Provide Lenire?

Hearing care professionals interested in providing the Lenire tinnitus treatment device can register their interest, and a member of the team will be in touch.

Neuromod helps Lenire Providers position their practice as a leader in tinnitus care, and ensure tinnitus patient outcome excellence with Neuromod Clinical Support

• Lenire Onboarding: Comprehensive onboarding, and an online tinnitus and Lenire learning platform.
• Lenire Network: Access a global network of tinnitus experts, KOLs, and referring healthcare providers.
• Lenire Support: Our dedicated clinical affairs and technical support allows you to focus on patient care.

Neuromod is a partner in tinnitus care excellence ensuring that Lenire can help you serve your tinnitus patients, and grow your clinic.